Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2009 1
2010 2
2011 2
2012 6
2013 4
2014 4
2015 2
2016 3
2017 3
2018 4
2019 3
2020 2
2021 3
2022 2
2023 4
2024 6
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Antibiotic allergy.
Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Blumenthal KG, et al. Among authors: peter jg. Lancet. 2019 Jan 12;393(10167):183-198. doi: 10.1016/S0140-6736(18)32218-9. Epub 2018 Dec 14. Lancet. 2019. PMID: 30558872 Free PMC article. Review.
Remibrutinib in Chronic Spontaneous Urticaria.
Metz M, Giménez-Arnau A, Hide M, Lebwohl M, Mosnaim G, Saini S, Sussman G, Szalewski R, Haemmerle S, Lheritier K, Martzloff ED, Seko N, Wang P, Zharkov A, Maurer M; REMIX-1 and REMIX-2 Investigators; REMIX-1 Investigators; REMIX-2 Investigators. Metz M, et al. N Engl J Med. 2025 Mar 6;392(10):984-994. doi: 10.1056/NEJMoa2408792. N Engl J Med. 2025. PMID: 40043237 Clinical Trial.
Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis.
Gibson A, Ram R, Gangula R, Li Y, Mukherjee E, Palubinsky AM, Campbell CN, Thorne M, Konvinse KC, Choshi P, Deshpande P, Pedretti S, Fear MW, Wood FM, O'Neil RT, Wanjalla CN, Kalams SA, Gaudieri S, Lehloenya RJ, Bailin SS, Chopra A, Trubiano JA; AUS-SCAR Consortium; Peter JG; AFRiSCAR Consortium; Mallal SA, Phillips EJ. Gibson A, et al. Among authors: peter jg. Nat Commun. 2024 Oct 8;15(1):8722. doi: 10.1038/s41467-024-52990-3. Nat Commun. 2024. PMID: 39379371 Free PMC article.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Among authors: peter jg. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Zhu F, Huang S, Liu X, Chen Q, Zhuang C, Zhao H, Han J, Jaen AM, Do TH, Peter JG, Dorado AG, Tirador LS, Zabat GMA, Villalobos REM, Gueco GP, Botha LLG, Iglesias Pertuz SP, Tan J, Zhu K, Quan J, Lin H, Huang Y, Jia J, Chu X, Chen J, Chen Y, Zhang T, Su Y, Li C, Ye X, Wu T, Zhang J, Xia N; COVID-19-PRO-003 Study Team. Zhu F, et al. Among authors: peter jg. Lancet Respir Med. 2023 Dec;11(12):1075-1088. doi: 10.1016/S2213-2600(23)00349-1. Epub 2023 Nov 15. Lancet Respir Med. 2023. PMID: 37979588 Free PMC article. Clinical Trial.
Long-term safety and efficacy of once-daily berotralstat in patients with hereditary angioedema: APeX-S final results.
Farkas H, Peter JG, Stobiecki M, Anderson J, Aygören-Pürsün E, Hagin D, Jeseňák M, Kessel A, Kiani-Alikhan S, Kinaciyan T, Manning M, Reshef A, Wu A, Iocca HA, Johnston DT, Noble L, Tomita D, Banerji A. Farkas H, et al. Among authors: peter jg. Ann Allergy Asthma Immunol. 2025 Sep;135(3):311-319.e6. doi: 10.1016/j.anai.2025.06.004. Epub 2025 Jun 7. Ann Allergy Asthma Immunol. 2025. PMID: 40490218 Free article. Clinical Trial.
Genetic polymorphisms and adverse reactions to antituberculosis therapy.
Gunter HM, Choshi P, Chimbetete T, Pedretti S, Lehloenya RJ, Sinxadi PZ, Ritchie MD, Phillips EJ, Haas DW, Peter JG. Gunter HM, et al. Among authors: peter jg. Pharmacogenomics. 2025 Apr-Apr;26(5-6):207-221. doi: 10.1080/14622416.2025.2509479. Epub 2025 Jun 20. Pharmacogenomics. 2025. PMID: 40538374 Free PMC article. Review.
HLA-B Alleles with Shared Peptide Binding Specificities Define Global Risk of Cotrimoxazole-induced SCAR.
Li Y, Gibson A, Saeed HN, Tahboub MA, Li D, Ostrov DA, Krantz MS, Mallal SA, Alves E, Chopra A, Choo L, Dodiuk-Gad RP, Kaffenberger B, Drucker AM, Goh MS, Ergen E, Micheletti R, Rosenbach M, Martin-Pozo MD, Gangula R, Williams EA, Yu A, O'Connor A, Mahan K, Kwan JT, Metcalfe D, Rashad R, Shanbhag SS, Pedretti S, Choshi P, Chimbetete T, Selim R, James I, Trubiano JA, Lehloenya R, Peter JG, Phillips EJ. Li Y, et al. Among authors: peter jg. medRxiv [Preprint]. 2025 May 28:2025.05.28.25328237. doi: 10.1101/2025.05.28.25328237. medRxiv. 2025. Update in: J Allergy Clin Immunol Pract. 2025 Nov;13(11):3042-3053. doi: 10.1016/j.jaip.2025.08.001. PMID: 40492078 Free PMC article. Updated. Preprint.
56 results